Author

Francesca Zammarchi

ADC Therapeutics (UK) Ltd , London ,ORCID 0000-0001-9457-2170Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

John M. MarisiD· 2 shared Matthew TsangiD· 2 shared Patrick H. van BerkeliD· 2 shared Yaël P. MosséiD· 2 shared Adam J. WolpawiD· 1 shared Alaa Narch· 1 shared Alberto DelaidelliiD· 1 shared Alexander B. RadaouiiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

John M. MarisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNeuro-OncologyPeer-reviewedJan 17, 2025

Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets

Nathan M. Kendsersky, Michal Odrobina, Nathaniel W. Mabe…·John M. Maris

This paper identifies cell state-dependent and -independent immunotherapeutic targets in neuroblastoma by analyzing subtype-specific gene expression and validating targets through experimental methods.

12 citationstop 4%

humanprotein sequence

𝕏 PostBluesky

Cancer BiologyCancer CellPeer-reviewedOct 24, 2024

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Amber K. Weiner, Alexander B. Radaoui, Matthew Tsang…·Sharon J. Diskin

This study identifies DLK1 as a potential immunotherapeutic target in neuroblastoma through integrative proteomic, transcriptomic, and epigenomic analysis.

28 citationstop 3%

humanproteomics

𝕏 PostBluesky